Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

SEROQUEL XR

QUETIAPINE FUMARATE

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SEROQUEL XR is listed in Drugs@FDA under application 022172 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient QUETIAPINE FUMARATE Form and strength TABLET, EXTENDED RELEASE; ORAL - 200MG Sponsor CHEPLAPHARM ARZNEIMITTEL GMBH Submission history Latest submission status date: 2007-11-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview SEROQUEL XR is listed in Drugs@FDA under application 022172 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient QUETIAPINE FUMARATE Form and strength TABLET, EXTENDED RELEASE; ORAL - 200MG Sponsor CHEPLAPHARM ARZNEIMITTEL GMBH Submission history Latest submission status date: 2007-11-15 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.